Prospective randomized trial of docetaxel versus mitomycin plus vinblastine in patients with metastatic breast cancer progressing despite previous anthracycline-containing chemotherapy. 304 Study Group.

Nabholtz, J M

Prospective randomized trial of docetaxel versus mitomycin plus vinblastine in patients with metastatic breast cancer progressing despite previous anthracycline-containing chemotherapy. 304 Study Group. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology May 1999 - 1413-24 p. digital

Publication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

0732-183X

10.1200/JCO.1999.17.5.1413 doi


Adult
Aged
Analysis of Variance
Antineoplastic Agents--administration & dosage
Breast Neoplasms--drug therapy
Disease Progression
Docetaxel
Drug Administration Schedule
Drug Resistance, Neoplasm
Female
Health Status
Humans
Middle Aged
Mitomycins--administration & dosage
Neutropenia--chemically induced
Paclitaxel--administration & dosage
Patient Compliance
Proportional Hazards Models
Prospective Studies
Survival Analysis
Taxoids
Thrombocytopenia--chemically induced
Vinblastine--administration & dosage